Skip to main content

Table 3 Number of components (Metabolic score) and prevalence of Metabolic Syndrome among different PPARγ and ACE genotypes in all the subjects studied and in the untreated patients group

From: PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome

   All Subjects
   Pro12Ala ACE I/D
   PP (334) XA (30) p DD (137) ID (172) II (55) P
All
(n 364)
Metabolic score (n) 2.6 ± 1.2 2.4 ± 1.2 0.53a 2.7 ± 1.3 2.5 ± 1.2 2.4 ± 1.1 0.23a
  Metabolic syndrome (%) 53.3 53.4 0.57b 58.7 51.5 45.5 0.20b
   PP (143) XA (18)   DD (55) ID (84) II (22)  
Not treated
(n 161)
Metabolic score (n) 2.01 ± 1.2 2.11 ± 1.1 0.74 2.11 ± 1.2 2.10 ± 1.2 1.55 ± 1 0.09
  Metabolic syndrome (%) 33.6 38.9 0.42 42.9 34.9 9.1 0.018 b
  1. a ANOVA. b Chi-square analysis